Linda Llewelyn - Apr 18, 2022 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role
Chief People Officer
Signature
/s/ Daniel Orenstein, as Attorney-in-Fact
Stock symbol
HCAT
Transactions as of
Apr 18, 2022
Transactions value $
-$46,050
Form type
4
Date filed
4/21/2022, 07:10 PM
Previous filing
Mar 17, 2022
Next filing
May 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCAT Common Stock Sale -$41.4K -1.84K -2.87% $22.52 62.2K Apr 18, 2022 Direct F1, F2
transaction HCAT Common Stock Sale -$4.64K -200 -0.32% $23.21 62K Apr 18, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1.
F2 Represents the weighted average sale price of the shares sold ranging from $22.14 to $22.92 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.